ACCORD HEALTHCARE LIMITED
Location
Founded
2004-04-13
Risk Signals
337 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products, Pharmaceutical Preparations, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about ACCORD HEALTHCARE LIMITED
Live alerts from global media, monitored by Business Radar
2024-01-25 (pmlive.com)
ACCORD: new guideline to support consistent and complete reporting of consensus methods in biomedical research
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies.
Read more
2022-09-15 (pharmaphorum.com)
Spotlight on the future of generics
Generic drugs play a vital role in ensuring affordable access to healthcare and the future sustainability of medicines development. Learn more in this series of resources sponsored by Accord Healthcare.
Read more
2021-09-27 (guidelinesinpractice.co.uk)
Sixmo®▼ (buprenorphine) 74.2 mg implant
Information intended for UK healthcare professionals only. This formulary decision guide was developed from content provided by Accord Healthcare Limited in a format developed by Guidelines in Practice.View prescribing information and adverse event
Read more
2020-06-05 (pharmaceutical-journal.com)
Heparin and zilucoplan added to COVID-19 ACCORD trials platform
The National Institute for Health Research has confirmed that two more drugs will be included in a clinical trial scheme designed to speed up development of new medicines for patients hospitalised with COVID-19.
Read more